Login / Signup
A cross-sectional study of vitreous and serum high mobility group box-1 levels in proliferative diabetic retinopathy.
Yinchen Shen
Hui Cao
Feng'e Chen
Yan Suo
Ning Wang
Xun Xu
Published in:
Acta ophthalmologica (2019)
Our findings suggest that HMGB-1 is involved in PDR disorders, and it may be a novel therapeutic target to inhibit progression of PDR.
Keyphrases
</>
diabetic retinopathy
optical coherence tomography
transcription factor
physical activity
binding protein
risk factors